EVX Ventures | 2021 Year In ReviewevxmarketingJan 28, 20221 min readUpdated: Jan 31, 2022 We are absolutely thrilled to share EVX Ventures’ 2021 Year in Review. Check out our latest Year in Review to learn more:2021 YEAR IN REVIEW_EVX NEWSLETTER_A4_012822 v5 compressed.pdfDownload PDF • 1.32MB
Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific Advisory BoardSINGAPORE and SHANGHAI, Dec. 19, 2022 -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey...
Carmine Therapeutics Announces First Close of Series A to Develop Non-viral Gene TherapyCambridge, MA, October 13, 2022 -- Carmine Therapeutics (“Carmine”), an EVX founded biotech company and emerging leader in non-viral gene...
Cargene Biopharma Welcomes Kathy He as CEOCargene Biopharma Welcomes Kathy He as CEO, to Accelerate Novel Oligonucleotide Therapeutics Development SINGAPORE, BOSTON and SHANGHAI...
acehbola
acehbola
acehbola
acehbola
acehbola
acehbola
aceh4d
aceh4d
aceh4d
aceh4d
aceh4d
aceh4d